STOCK TITAN

AdaptHealth Corp. - AHCO STOCK NEWS

Welcome to our dedicated page for AdaptHealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on AdaptHealth stock.

AdaptHealth Corp. (NASDAQ: AHCO) is a leading provider of patient-centered, healthcare-at-home solutions across the United States. Operating in 47 states, AdaptHealth offers a comprehensive range of home medical equipment (HME) and services to help patients manage chronic conditions and improve their quality of life in the comfort of their homes.

Founded on the principle that everyone deserves a comfortable and independent life, AdaptHealth's offerings include sleep and respiratory therapy, diabetes management supplies, mobility products, wound care, non-invasive ventilation, and nutritional support. Their clinically-focused services assist patients with daily living activities, supporting approximately 4.1 million patients annually through a network of around 670 locations.

The company's core offerings include sleep therapy equipment (including CPAP and biPAP services) for those with obstructive sleep apnea, medical devices for diabetes management (such as continuous glucose monitors and insulin pumps), and oxygen therapy and related chronic care services. Additionally, AdaptHealth provides specialized HME devices and supplies for wound care, urological, incontinence, ostomy, and nutritional needs.

AdaptHealth is renowned for its extensive partnerships with a diverse network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. The company serves beneficiaries of Medicare, Medicaid, and commercial insurance payors, making it a cornerstone in the provision of at-home medical care in the U.S.

Despite facing challenges, AdaptHealth has shown remarkable financial resilience and growth. The company reported a net revenue of $793.3 million for the second quarter of 2023, an increase of 9% compared to the same period in 2022. Their adjusted EBITDA reached $171.0 million, up by 14%, showcasing robust financial health and operational efficiency.

Going forward, AdaptHealth continues to focus on enhancing its service offerings and operational efficiency under new leadership. The recent appointment of Suzanne Foster as Chief Executive Officer marks a significant step in the company’s strategic direction, aimed at furthering its mission to deliver high-quality, patient-centered care.

For more detailed financial results and updates, visit AdaptHealth’s official website.

Rhea-AI Summary
AdaptHealth Corp. (NASDAQ: AHCO) announced Q3 2023 financial results with a 6.3% increase in net revenue to $804.0 million, a net loss of $454.1 million mainly due to a $511.9 million pre-tax write down of goodwill, and an adjusted EBITDA of $161.2 million. The company also updated its fiscal year 2023 guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.99%
Tags
-
Rhea-AI Summary
AdaptHealth Corp. to release third quarter 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
-
Rhea-AI Summary
AdaptHealth Corp. to participate in Baird's 2023 Global Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.7%
Tags
conferences
Rhea-AI Summary
AdaptHealth Corp. (NASDAQ: AHCO) reported a 9.0% increase in net revenue to $793.3 million for the second quarter of 2023 compared to the same period in 2022. Adjusted EBITDA also increased by 14.0% to $171.0 million. The company is well-positioned for the second half of the year and has updated its fiscal year 2023 financial guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.38%
Tags
-
Rhea-AI Summary
AdaptHealth Corp. (NASDAQ: AHCO) announced that its Chairman and interim CEO, President, and CFO will participate in the Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023. The conference will include a fireside chat at 9:30am ET. A replay of the presentation will be available on the company's website for 90 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.2%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.62%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.81%
Tags
conferences
-
Rhea-AI Summary
J. Anton Hie joins Community Health Systems as Vice President of Investor Relations. Hie has over 20 years of experience in the healthcare investment field. He previously worked at AdaptHealth Corp. and RBC Capital Markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.81%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.77%
Tags
partnership

FAQ

What is the current stock price of AdaptHealth (AHCO)?

The current stock price of AdaptHealth (AHCO) is $10.28 as of December 20, 2024.

What is the market cap of AdaptHealth (AHCO)?

The market cap of AdaptHealth (AHCO) is approximately 1.3B.

What services does AdaptHealth Corp. provide?

AdaptHealth offers a range of healthcare-at-home services including sleep therapy, diabetes management, respiratory therapy, mobility products, wound care, and nutritional support.

Where does AdaptHealth operate?

AdaptHealth operates in 47 states across the United States, serving approximately 4.1 million patients annually through its network of around 670 locations.

What is included in AdaptHealth’s sleep therapy services?

AdaptHealth's sleep therapy services include CPAP and biPAP equipment and related services to assist individuals suffering from obstructive sleep apnea.

How does AdaptHealth assist patients with diabetes?

AdaptHealth provides medical devices and supplies for diabetes management, such as continuous glucose monitors and insulin pumps.

What recent financial performance has AdaptHealth reported?

AdaptHealth reported a net revenue of $793.3 million for Q2 2023, a 9% increase from Q2 2022, with an adjusted EBITDA of $171.0 million, showing a 14% rise.

Who is the current CEO of AdaptHealth Corp.?

Suzanne Foster is the newly appointed Chief Executive Officer of AdaptHealth Corp., as of May 20, 2024.

What kind of equipment does AdaptHealth provide for respiratory therapy?

AdaptHealth offers home oxygen therapy equipment and related chronic care services to patients.

How does AdaptHealth support wound care?

AdaptHealth provides specialized home medical equipment and supplies for wound care, including products for urological, incontinence, ostomy, and nutritional needs.

What partnerships does AdaptHealth have?

AdaptHealth partners with a diverse network of referral sources including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics.

How can investors get more information about AdaptHealth?

Investors can visit AdaptHealth’s official website and navigate to the 'Investor Relations' section for the latest financial reports and updates.

AdaptHealth Corp.

Nasdaq:AHCO

AHCO Rankings

AHCO Stock Data

1.32B
103.37M
11.93%
94.93%
7.41%
Medical Devices
Services-home Health Care Services
Link
United States of America
PLYMOUTH MEETING